NIH-funded research R01 grant

DNA methylation and chronic low back pain

Official title: Epigenetic Drivers of Chronic Low Back Pain

Funded at University of Minnesota · NIH-11181647 · Data updated 2026-11-12

This project looks at how DNA on/off switches (DNA methylation) change in people with long-term low back pain to find new ways to treat disc-related pain.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Minnesota
NIH-funded
Lab location1 site (Minneapolis, United States)
Project startSeptember 3, 2024
Project endJune 30, 2029
Funding year2025
Award (this year)$581,658
NIH project number5R01AR083365-02
Project IDNIH-11181647 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults with chronic low back pain thought to come from intervertebral disc degeneration, including patients undergoing spinal surgery who can donate disc tissue.

Less likely to help

People with short-term (acute) back pain or pain clearly caused by non-disc problems (like fractures, infection, or cancer) are unlikely to benefit from this specific research.

What this research studies

You may be asked to provide disc tissue if you have surgery or to allow your clinical data and samples to be studied alongside lab work. Researchers will map DNA methylation patterns in degenerated intervertebral discs and compare them to healthier tissue. They will use laboratory experiments and animal models to test whether changing methylation alters gene activity that drives disc degeneration. The goal is to find molecular targets that could be used to develop new treatments for chronic discogenic low back pain.

Why it matters

Potential benefit: If successful, this work could point to new treatments that reduce or reverse disc degeneration and lower chronic low back pain by targeting DNA methylation.

How similar studies have gone: Early studies have found links between DNA methylation and chronic pain, but applying epigenetic targeting to treat disc degeneration is largely new and not yet proven in patients.

Where this research is happening

  • University of Minnesota
    Minneapolis, United States
    Active

Researchers

  • Principal investigator: Stone, Laura S — University of Minnesota
  • Study coordinator: Stone, Laura S

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.